Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
PremiumPress ReleasesAcasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
3M ago
Acasti Pharma achieves 50% enrollment in STRIVE-ON safety trial
Premium
The Fly
Acasti Pharma achieves 50% enrollment in STRIVE-ON safety trial
3M ago
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
Premium
Press Releases
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
7M ago
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
Premium
Press Releases
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
7M ago
Acasti Pharma reports Q3 EPS (21c) vs (52c) last year
Premium
The Fly
Acasti Pharma reports Q3 EPS (21c) vs (52c) last year
7M ago
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
PremiumPress ReleasesAcasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
8M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024
Premium
Press Releases
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100